August 19, 2025

SNDA submitted to FDA for venetoclax, acalabrutinib combo in CLL

The US Food and Drug Administration (FDA) received the supplemental New Drug Application for venetoclax (VENCLEXTA) and acalabrutinib (Calquence), an.

Top Categories

POPULAR NEWS

SOHO Insider Podcast

Meetings

Young Investigator Program

Ambassador Program

MEMBERS

Editorial Board

Members Strong

Join Us Today and Become a Part of the SOHO Community

Benefits of membership include:

Career

SOHO Career Center

The Career Center provides SOHO members with the ability to find jobs in the field of Hematologic Oncology along with a variety of career advice. Select the 'Career Center' button to explore new job opportunities and career information.

The Career Center Allows SOHO Members to:

To access the SOHO Career Center click the following link.